Davidson Kempner Capital Management »

Apogee Therapeutics shares owned by Davidson Kempner Capital Management

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Davidson Kempner Capital Management from 13F filings

Historical chart of Davidson Kempner Capital Management investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Davidson Kempner Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Davidson Kempner Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $213k 10k 21.27

More positions owned by Davidson Kempner Capital Management

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Verona Pharma Sponsored Ads (VRNA)
Seagate Hdd Cayman Note 3.500% 6/0 (Principal)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Pdd Holdings Note 12/0 (Principal)
Meta Platforms Cl A (META)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Uber Technologies Note 0.875%12/0 (Principal)
Jd.com Note 0.250% 6/0 (Principal)
Amazon (AMZN)
Arko Corp (ARKO)
Rivian Automotive Note 4.625% 3/1 (Principal)
Redfin Corp Note 0.500% 4/0 (Principal)
NVIDIA Corporation (NVDA)
Snowflake Note 10/0 (Principal)

View all positions for Davidson Kempner Capital Management

Top funds holding Apogee Therapeutics

VR Adviser
FMR
Wellington Management Company
Rtw Investments
BlackRock
Vanguard Group
Driehaus Capital Management
Fairmount Funds Management
State Street Corporation
Paradigm Biocapital Advisors
Braidwell
Alliancebernstein
Perceptive Advisors
Citadel Advisors
Affinity Asset Advisors

View all funds holding Apogee Therapeutics